Cargando…

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin

Doxorubicin is the most frequently used chemotherapeutic agent for the treatment of hepatocellular carcinoma. However, one major obstacle to the effective management of liver cancer is the drug resistance derived from the cancer stem cells. Herein, we employed a CD133 aptamer for targeted delivery o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Wang, Pham, Cuong V., Wang, Tao, Al Shamaileh, Hadi, Chowdhury, Rocky, Patel, Shweta, Li, Yong, Kong, Lingxue, Hou, Yingchu, Zhu, Yimin, Chen, Sunrui, Xu, Huo, Jia, Lee, Duan, Wei, Xiang, Dongxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687680/ https://www.ncbi.nlm.nih.gov/pubmed/36358973 http://dx.doi.org/10.3390/biom12111623

Ejemplares similares

Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2017)

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2020)

Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
por: Shigdar, Sarah, et al.
Publicado: (2013)

EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015)

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017)

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
por: Yin, Wang, et al.
Publicado: (2021)

Aptamer-guided extracellular vesicle theranostics in oncology
por: Tran, Phuong H-L, et al.
Publicado: (2020)

Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
por: Xiang, Dongxi, et al.
Publicado: (2015)

Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
por: Xiang, Dongxi, et al.
Publicado: (2015)

Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against α-Bungarotoxin
por: Lauridsen, Lasse H., et al.
Publicado: (2012)

Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
por: Rahimizadeh, Kamal, et al.
Publicado: (2017)

Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells
por: Esawi, Ezaldeen, et al.
Publicado: (2021)

Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
por: Yao, Fengjiao, et al.
Publicado: (2020)

Development of Blueberry-Derived Extracellular Nanovesicles for Immunomodulatory Therapy
por: Nguyen, Tuong Ngoc-Gia, et al.
Publicado: (2023)

Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
por: Hu, Yan, et al.
Publicado: (2018)

Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
por: Ma, Qi, et al.
Publicado: (2019)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xie, Xiaodong, et al.
Publicado: (2019)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells
por: Li, Lei, et al.
Publicado: (2014)

Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
por: An, Yacong, et al.
Publicado: (2019)

Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers
por: Abdollahzade, Aref, et al.
Publicado: (2023)

Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell
por: Lohlamoh, Walaiporn, et al.
Publicado: (2021)

Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xie, Xiaodong, et al.
Publicado: (2020)

Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
por: Huang, Xiaolong, et al.
Publicado: (2017)

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
por: Subramanian, Nithya, et al.
Publicado: (2012)

Recycling endosomal CD133 functions as an inhibitor of autophagy at the pericentrosomal region
por: Izumi, Hideki, et al.
Publicado: (2019)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017)

Aptamer‐targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7‐positive tumours
por: Liu, Mengting, et al.
Publicado: (2018)

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
por: Xu, Xiao Dong, et al.
Publicado: (2017)

Targeting lung cancer initiating cells by all-trans retinoic acid-loaded lipid-PLGA nanoparticles with CD133 aptamers
por: Zhang, Yu, et al.
Publicado: (2018)

CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
por: Chen, Haiyang, et al.
Publicado: (2013)

Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model
por: Lin, Jia, et al.
Publicado: (2014)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
por: Porciani, David, et al.
Publicado: (2015)

Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer
por: Atabi, Fereshteh, et al.
Publicado: (2017)

Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein
por: Chandra, Sruti, et al.
Publicado: (2020)

Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin
por: Song, Xinyue, et al.
Publicado: (2021)

PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells
por: Go, Gyeongyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1r1gbk4hime8fh69t68o813o8